logo
#

Latest news with #StifelNicolaus

Stifel Nicolaus upgrades Meridian Mining SE (MNO) to a Buy
Stifel Nicolaus upgrades Meridian Mining SE (MNO) to a Buy

Business Insider

time3 days ago

  • Business
  • Business Insider

Stifel Nicolaus upgrades Meridian Mining SE (MNO) to a Buy

Meridian Mining SE (MNO – Research Report) received a Buy rating and price target from Stifel Nicolaus analyst Cole McGill yesterday. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, McGill is an analyst with an average return of -16.1% and a 29.05% success rate. McGill covers the Basic Materials sector, focusing on stocks such as Foran Mining, Montage Gold Corp., and Silver Tiger Metals. The word on The Street in general, suggests a Hold analyst consensus rating for Meridian Mining SE.

‘Time to Choose Sides on Salesforce (NYSE:CRM),' Analysts are Split on the Stock
‘Time to Choose Sides on Salesforce (NYSE:CRM),' Analysts are Split on the Stock

Globe and Mail

time3 days ago

  • Business
  • Globe and Mail

‘Time to Choose Sides on Salesforce (NYSE:CRM),' Analysts are Split on the Stock

Salesforce (CRM) has received mixed analyst ratings following its better-than-expected Q1 earnings report, reflecting differing views on the company's growth strategy. While Stifel Nicolaus analyst upgraded rating to Buy, citing AI-driven expansion, RBC Capital opted for a downgrade, noting acquisition risks and growth uncertainties. Confident Investing Starts Here: Stifel Reaffirms Buy Rating on CRM Stock Analyst J. Parker Lane of Stifel Nicolaus maintained a Buy rating with a price target of $375, citing strong position in AI and growth potential of its tools like Agentforce, Data Cloud, MuleSoft, and Tableau. He noted that Salesforce's management expect these products to drive sales growth. Lane pointed to CRM's growing its sales reach and adjusting pay plans to boost growth while keeping profits strong. Also, the analyst believes that the company's multi-product deals and success with smaller businesses show big potential. Lane has set a $375 price target (40.5% upside potential) for Salesforce stock. RBC Analyst Sees Acquisition Risks Not all analysts share Lane's optimism. Post Q1 results, RBC Capital's Rishi Jaluria downgraded Salesforce to Hold from Buy, slashing the price target to $275 (3% upside) from $420. Jaluria's main concern is Salesforce's $8 billion acquisition of Informatica (INFA). The analyst believes the deal, while expanding CRM's data capabilities, raises longer-term risks regarding integration and financial impact. Is CRM a Buy, Hold, or Sell? Turning to Wall Street, CRM stock has a Moderate Buy consensus rating based on 32 Buys, nine Holds, and three Sells assigned in the last three months. At $350.63, the average Salesforce stock price target implies a 31.36% upside potential. See more CRM analyst ratings

Goliath Resources Announces Bought Deal Private Placement of Charity Flow-Through Financing for Gross Proceeds of C$20,002,700
Goliath Resources Announces Bought Deal Private Placement of Charity Flow-Through Financing for Gross Proceeds of C$20,002,700

Globe and Mail

time5 days ago

  • Business
  • Globe and Mail

Goliath Resources Announces Bought Deal Private Placement of Charity Flow-Through Financing for Gross Proceeds of C$20,002,700

TORONTO , May 29, 2025 /CNW/ - Goliath Resources Limited (TSXV: GOT) (OTCQB: GOTRF) (Frankfurt: B4IF) (the " Company" or " Goliath") is pleased to announce that it has entered into an agreement with Stifel Nicolaus Canada Inc. to act as sole bookrunner and lead underwriter, together with a syndicate of underwriters (collectively, the " Underwriters"), in connection with a "bought deal" private placement offering by the Company of 6,310,000 common shares of the Company (the " Charity Flow-Through Shares") that will qualify as "flow-through shares" as defined in subsection 66(15) of the Income Tax Act ( Canada ) (the " Tax Act") at a price of C$3 .17 per Charity Flow-Through Share (the " Issue Price") for gross proceeds of C$20,002 ,700 (the " Offering"). The Company has granted the Underwriters an option to sell such number of additional Charity Flow-Through Shares as is equal to 15% of the number of Charity Flow-Through Shares sold under the Offering at the Issue Price (the " Underwriters' Option"). The Underwriters' Option will be exercisable, in whole or in part, at any time up until 48 hours prior to the closing date of the Offering (the " Closing Date"). In consideration for the services provided to the Company in connection with the Offering, the Underwriters will be entitled to receive a cash commission equal to 6.0% of the gross proceeds raised under the Offering (the " Cash Commission") and such number of broker warrants (" Broker Warrants") as is equal to the number of Charity Flow-Through Shares sold under the Offering. Each Broker Warrant will entitle the holder thereof to acquire one common share of the Company at a price of C$1.95 for a period of 24 months following the closing date of the Offering. For the avoidance of doubt, the Cash Commission will be paid from the Company's cash on hand and not from the gross proceeds received by the Company under the Offering. The Offering is expected to close on or about June 16, 2025 , and is subject to certain conditions including the receipt of all necessary approvals such as the approval of the TSX Venture Exchange (the " Exchange"). The Company will use the gross proceeds of the Offering to incur Qualifying Expenditures (as defined here) on the Company's flagship Golddigger-Surebet Gold Project, located in British Columbia, Canada . The gross proceeds from the Charity Flow-Through Shares will be used to incur exploration expenses that qualify as "Canadian exploration expenses" as defined in subsection 66.1(6) of the Tax Act, "flow-through mining expenditures" as defined in subsection 127(9) of the Tax Act for purposes of the mineral exploration tax credit, and for individual subscribers resident in British Columbia , "BC flow-through mining expenditures" as defined in subsection 4.721(1) of the Income Tax Act ( British Columbia ) (the " Qualifying Expenditures"). Such expenses will be incurred on or before December 31, 2026 , and renounced to the subscribers with an effective date no later than December 31, 2025 . The "BC mining flow-through share tax credit" allows individual residents of British Columbia who invest in flow-through shares to claim a provincial non-refundable tax credit in an amount equal to 20% of such subscriber's "BC flow-through mining expenditures". In connection with the Offering, certain purchasers of Charity Flow-Through Shares intend to subsequently (i) donate some or all of such Charity Flow-Through Shares to registered charities, who may sell such Charity Flow-Through Shares to purchasers arranged by the Underwriters, and/or (ii) sell some or all of such Charity Flow-Through Shares to purchasers arranged by the Underwriters, in each case on the Closing Date (such Charity Flow-Through Shares described in (i) and (ii), being the " Re-Offer Shares"), and at a price of C$1.95 per Re-Offer Share. Sales of Re-Offer Shares may be made to purchasers located in (i) each of the provinces of Canada , other than Québec, pursuant to the Listed Issuer Financing Exemption, (ii) the United States pursuant to available exemptions from the registration requirements of applicable United States securities laws, and (iii) such other jurisdictions provided it is understood that no prospectus filing or comparable obligation, ongoing reporting requirement or requisite regulatory or governmental approval arises in such other jurisdictions Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions (" NI 45-106"), the Charity Flow-Through Shares will be offered for sale to purchasers resident in Canada , except Quebec , and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the " Listed Issuer Financing Exemption"). As the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the Charity Flow-Through Shares issued pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company's issuer profile on SEDAR+ at and on the Company's website at Prospective investors should read the offering document before making an investment decision. The Broker Warrants and shares that will be issuable upon the exercise thereof (if any) will be issued pursuant to available exemptions under NI 45-106 other than the Listed Issuer Financing Exemption and, accordingly, will be subject to a hold period expiring four months and one day following the closing date of the Offering. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States . The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " 1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. About Goliath Resources Limited Goliath is an explorer of precious metals projects in the prolific Golden Triangle of northwestern British Columbia . All of its projects are in high quality geological settings and geopolitical safe jurisdictions amenable to mining in Canada . Goliath is a member and active supporter of CASERM which is an organization that represents a collaborative venture between Colorado School of Mines and Virginia Tech. Goliath's key strategic cornerstone shareholders include Crescat Capital, McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), Mr. Rob McEwen , a Global Commodity Group based in Singapore , Mr. Eric Sprott and Mr. Larry Childress . This press release contains statements that constitute "forward-looking information" (" forward-looking information") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking information and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information. Forward-looking statements in this news release include statements regarding the Offering (including the completion of the Offering on the terms and timeline as announced or ats all, the tax treatment of the Charity Flow-Through Shares, the timing to incur and renounce all Qualifying Expenditures in favour of the subscribers, and the use of proceeds of the Offering), and the Company's ability to obtain all regulatory approvals, including the approval of the Exchange. In disclosing the forward-looking information contained in this press release, the Company has made certain assumptions. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, it can give no assurance that the expectations of any forward-looking information will prove to be correct. Known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Such factors include but are not limited to: compliance with extensive government regulations; domestic and foreign laws and regulations adversely affecting the Company's business and results of operations; and general business, economic, competitive, political and social uncertainties. Accordingly, readers should not place undue reliance on the forward-looking information contained in this press release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking information to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking information or otherwise. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Stifel Nicolaus Maintains Buy Rating on Salesforce (CRM)
Stifel Nicolaus Maintains Buy Rating on Salesforce (CRM)

Yahoo

time5 days ago

  • Business
  • Yahoo

Stifel Nicolaus Maintains Buy Rating on Salesforce (CRM)

On May 29, analyst J. Parker Lane of Stifel Nicolaus maintained a Buy rating on Salesforce, Inc. (NYSE:CRM) and kept a price target of $375.00. The rating update followed the company's fiscal Q1 2026 earnings report on May 28 and reflects the analyst's confidence in CRM's strategic positioning in the AI space and its considerable growth potential, driven by innovative solutions such as MuleSoft, Agentforce, Data Cloud, and Tableau. A customer service team in an office setting using the company's Customer 360 platform to communicate with customers. The analyst stated that management has also expressed confidence in the company's innovative technological capabilities, expecting them to bolster Salesforce, Inc.'s (NYSE:CRM) market presence and support revenue growth. The company's fiscal Q1 2026 results showed an 8% year-over-year growth in revenue which amounted to $9.8 billion. Its subscription and support revenue also increased by 8% year-over-year, reaching $9.3 billion. The analyst further commented that Salesforce, Inc.'s (NYSE:CRM) focus on adjusting compensation structures and expanding its go-to-market capabilities demonstrates a commitment to expediting growth while ensuring margin expansion. Although Salesforce, Inc.'s (NYSE:CRM) is in the early stages of monetizing its AI capabilities, the analyst expressed confidence in its potential to land multi-product deals. In addition, he stated that the company's traction in the mid-market segments and SMB points towards a promising outlook, supporting the Buy rating. While we acknowledge the potential of CRM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CRM and that has 100x upside potential, check out our report about the . READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Kymera Therapeutics (KYMR) Initiated with a Buy at Stifel Nicolaus
Kymera Therapeutics (KYMR) Initiated with a Buy at Stifel Nicolaus

Business Insider

time26-05-2025

  • Business
  • Business Insider

Kymera Therapeutics (KYMR) Initiated with a Buy at Stifel Nicolaus

In a report released today, Alex Thompson CFA from Stifel Nicolaus initiated coverage with a Buy rating on Kymera Therapeutics (KYMR – Research Report) and a price target of $55.00. The company's shares closed last Friday at $29.49. Confident Investing Starts Here: Thompson CFA covers the Healthcare sector, focusing on stocks such as Viridian Therapeutics, Argenx Se, and Travere Therapeutics. According to TipRanks, Thompson CFA has an average return of -5.8% and a 40.68% success rate on recommended stocks. In addition to Stifel Nicolaus, Kymera Therapeutics also received a Buy from UBS's Eliana Merle in a report issued on May 13. However, on May 12, Bank of America Securities reiterated a Hold rating on Kymera Therapeutics (NASDAQ: KYMR). Based on Kymera Therapeutics' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $22.1 million and a GAAP net loss of $65.58 million. In comparison, last year the company earned a revenue of $10.29 million and had a GAAP net loss of $48.56 million Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of KYMR in relation to earlier this year. Most recently, in March 2025, Jeremy Chadwick, the COO of KYMR sold 1,383.00 shares for a total of $42,103.92.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store